Molecular epidemiology and genomic characteristics of clinical Acinetobacter baumannii isolates from patients with hospital-acquired pneumonia in China, 2019–2020: a multicentre retrospective study
Jintao He, Qingye Xu, Minfei Peng, Haiyang Liu, Li Fang, Siyuan Yang, Yisha Zhang, Hanqi Zhang, Xiaochen Liu, Xi Li, Xiaoting Hua, Yunsong Yu, Hua Zhou · 2026
Read Molecular epidemiology and genomic characteristics of clinical Acinetobacter baumannii isolates from patients with hospital-acquired pneumonia in China, 2019–2020: a multicentre retrospective study by Jintao He, Qingye Xu, Minfei Peng, Haiyang Liu, Li Fang, Siyuan Yang, Yisha Zhang, Hanqi Zhang, Xiaochen Liu, Xi Li, Xiaoting Hua, Yunsong Yu, Hua Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13597179.txt.
Description
Jintao He leads a large team in charting a drug-proof germ behind hospital lung infections across China. The paper is from two thousand twenty-six. The germ, Acinetobacter baumannii, shrugs off carbapenem drugs in most cases and drives high death rates. Large nationwide data on the pneumonia form were scarce.
They read the genomes of over eight hundred samples from dozens of hospitals for two years. Four in five prove drug-proof, and deaths run far higher in those cases than in tame ones. One strain type rules, and one gene drives most of the drug proof. Some drugs still work. Strain families split by region, and one clone packs more harm genes than the rest.
Catalog record
| CREATOR | Jintao He, Qingye Xu, Minfei Peng, Haiyang Liu, Li Fang, Siyuan Yang, Yisha Zhang, Hanqi Zhang, Xiaochen Liu, Xi Li, Xiaoting Hua, Yunsong Yu, Hua Zhou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |